Polarean Imaging Plc (PLLWF)
OTHER OTC:PLLWF
PLLWF Stock Chart & Stats
$0.01
<$0.01(33.33%)
At close: 4:00 PM EST
$0.01
<$0.01(33.33%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume15.00K
Average Volume (3M)0.00
Market Cap
$1.29M
Enterprise Value$11.91M
Total Cash (Recent Filing)$7.29M
Total Debt (Recent Filing)$441.66K
Price to Earnings (P/E)―
Beta-1.96
Next Earnings
Jun 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,207,032,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.03
Price to Sales (P/S)5.15
P/FCF Ratio-2.88
Enterprise Value/Market Cap9.21
Enterprise Value/Revenue6.00
Enterprise Value/Gross Profit36.68
Enterprise Value/Ebitda-1.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$40.00K
Bulls Say, Bears Say
Bulls Say
Market ExpansionPolarean has signed a distribution agreement with Sumtage Enterprise for the distribution of Polarean’s Xenon MRI platform in Taiwan, marking Polarean's entry into the Taiwanese market.
Strategic CollaborationPolarean has signed a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the US.
Bears Say
Commercial Roll-OutA potential commercial roll-out in Taiwan seems unlikely until the second half of 2026.
Polarean Imaging News
PLLWF FAQ
What was Polarean Imaging Plc’s price range in the past 12 months?
Polarean Imaging Plc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Polarean Imaging Plc’s market cap?
Polarean Imaging Plc’s market cap is $1.29M.
When is Polarean Imaging Plc’s upcoming earnings report date?
Polarean Imaging Plc’s upcoming earnings report date is Jun 18, 2026 which is in 7 days.
How were Polarean Imaging Plc’s earnings last quarter?
Polarean Imaging Plc released its earnings results on Sep 25, 2025. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Polarean Imaging Plc overvalued?
According to Wall Street analysts Polarean Imaging Plc’s price is currently Overvalued.
Does Polarean Imaging Plc pay dividends?
Polarean Imaging Plc does not currently pay dividends.
What is Polarean Imaging Plc’s EPS estimate?
Polarean Imaging Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Polarean Imaging Plc have?
Polarean Imaging Plc has 1,207,032,800 shares outstanding.
What happened to Polarean Imaging Plc’s price movement after its last earnings report?
Polarean Imaging Plc reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Polarean Imaging Plc?
Currently, no hedge funds are holding shares in PLLWF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Polarean Imaging Plc
Polarean Imaging plc is a medical technology company specializing in drug-device combinations, catering to the medical imaging industry across the U.S., Canada, Germany, and the U.K. Its core business involves the creation and market introduction of gas polarizer apparatus and their supporting accessories. Polarean crafts innovative equipment designed to upgrade conventional magnetic resonance imaging (MRI) scanners for detailed functional pulmonary assessment. A significant area of expertise is the application of hyperpolarized xenon gas (129Xe) as a unique imaging tracer. This allows for precise, regional visualization of ventilation and gas exchange within the lungs' most intricate airways, the vital tissue interface separating the lungs from the bloodstream, and the pulmonary vascular network, thereby presenting a groundbreaking diagnostic methodology. Additionally, the firm undertakes the design and production of specialized MRI radiofrequency coils, essential components for conducting 129Xe imaging within an MRI framework. Established in 2016, Polarean Imaging plc has its operational base in Durham, North Carolina.